litlas
Log inCreate account

Glenn Dranoff

Active 1993–2025

127
Papers
41,857
Citations
99
h-index
125
i10-index

Citations

Citations per year for Glenn Dranoff1994: 6 citations1995: 24 citations1996: 34 citations1997: 30 citations1998: 72 citations1999: 80 citations2000: 122 citations2001: 118 citations2002: 128 citations2003: 143 citations2004: 158 citations2005: 176 citations2006: 160 citations2007: 157 citations2008: 238 citations2009: 261 citations2010: 269 citations2011: 263 citations2012: 294 citations2013: 394 citations2014: 391 citations2015: 492 citations2016: 617 citations2017: 703 citations2018: 863 citations2019: 1,878 citations2020: 2,143 citations2021: 2,088 citations2022: 1,629 citations2023: 1,313 citations2024: 1,793 citations2025: 832 citations2026: 33 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 6,478 citing papers, 29.6% of this breakdownChina: 3,978 citing papers, 18.2% of this breakdownGermany: 983 citing papers, 4.5% of this breakdownUnited Kingdom: 937 citing papers, 4.3% of this breakdownJapan: 813 citing papers, 3.7% of this breakdownFrance: 807 citing papers, 3.7% of this breakdownItaly: 785 citing papers, 3.6% of this breakdownAustralia: 597 citing papers, 2.7% of this breakdownSwitzerland: 491 citing papers, 2.3% of this breakdownCanada: 483 citing papers, 2.2% of this breakdownSouth Korea: 443 citing papers, 2% of this breakdownNetherlands: 438 citing papers, 2% of this breakdown
0%29.6%Other 21.2%

Institutions

Fields

  • Medicine46.9%
  • Immunology and Microbiology25.9%
  • Biochemistry, Genetics and Molecular Biology19.2%
  • Engineering4.2%
  • Materials Science1%
  • Neuroscience0.9%
  • Other1.9%

Topics

  • Cancer Immunotherapy and Biomarkers10.9%
  • Immunotherapy and Immune Responses9%
  • Immune Cell Function and Interaction6.2%
  • CAR-T cell therapy research5.2%
  • Immune cells in cancer4.1%
  • T-cell and B-cell Immunology2.4%
  • Other62.2%

Coauthors

All papers

Open in search
  1. Cancer immunotherapy comes of age

    Authors: Ira Mellman, George Coukos, Glenn Dranoff - Nature 2011 cited by 3,905

  2. Fusobacterium nucleatumin colorectal carcinoma tissue and patient prognosis

    Authors: Kosuke Mima, Reiko Nishihara, Zhi Rong Qian, Yin Cao, Yasutaka Sukawa, Jonathan A. Nowak, Juhong Yang, Ruoxu Dou, Yohei Masugi, Mingyang Song, Aleksandar D. Kostic, Marios Giannakis, Susan Bullman, Danny A. Milner, Hideo Baba, Edward L. Giovannucci, Levi A. Garraway, Gordon J. Freeman, Glenn Dranoff, Wendy S. Garrett, Curtis Huttenhower, Matthew Meyerson, Jeffrey A. Meyerhardt, Andrew T. Chan, Charles S. Fuchs, Shuji Ogino - Gut 2015 cited by 1,074

  3. Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints

    Authors: Shohei Koyama, Esra A. Akbay, Yvonne Y. Li, Grit S. Herter-Sprie, Kevin A. Buczkowski, William G. Richards, Leena Gandhi, Amanda J. Redig, Scott J. Rodig, Hajime Asahina, Robert E. Jones, Meghana Kulkarni, Mari Kuraguchi, Sangeetha Palakurthi, Peter E. Fecci, Bruce E. Johnson, Pasi A. Jänne, Jeffrey A. Engelman, Sidharta P. Gangadharan, Daniel B. Costa, Gordon J. Freeman, Raphael Bueno, F. Stephen Hodi, Glenn Dranoff, Kwok‐Kin Wong, Peter S. Hammerman - Nature Communications 2016 cited by 1,570

  4. Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors

    Authors: Pakawat Chongsathidkiet, Christina Jackson, Shohei Koyama, Franziska Loebel, Xiuyu Cui, S. Harrison Farber, Karolina Woroniecka, Aladine A. Elsamadicy, Cosette Dechant, Hanna Kemeny, Luis Sánchez-Pérez, Tooba A. Cheema, Nicholas Souders, James E. Herndon, Jean-Valéry Coumans, Jeffrey I. Everitt, Brian V. Nahed, John H. Sampson, Michael D. Gunn, Robert L. Martuza, Glenn Dranoff, William T. Curry, Peter E. Fecci - Nature Medicine 2018 cited by 664

  5. Combining immunotherapy and targeted therapies in cancer treatment

    Authors: Matthew W. Vanneman, Glenn Dranoff - Nature reviews. Cancer 2012 cited by 1,581

  6. T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma

    Authors: Karolina Woroniecka, Pakawat Chongsathidkiet, Kristen E. Rhodin, Hanna Kemeny, Cosette Dechant, S. Harrison Farber, Aladine A. Elsamadicy, Xiuyu Cui, Shohei Koyama, Christina Jackson, Landon J. Hansen, Tanner M. Johanns, Luis Sánchez-Pérez, Vidyalakshmi Chandramohan, Yen-Rei A. Yu, Darell D. Bigner, Amber Giles, Patrick Healy, Glenn Dranoff, Kent J. Weinhold, Gavin P. Dunn, Peter E. Fecci - Clinical Cancer Research 2018 cited by 646

  7. Fusobacterium nucleatumand T Cells in Colorectal Carcinoma

    Authors: Kosuke Mima, Yasutaka Sukawa, Reiko Nishihara, Zhi Rong Qian, Mai Yamauchi, Kentaro Inamura, Sun A. Kim, Atsuhiro Masuda, Jonathan A. Nowak, Katsuhiko Nosho, Aleksandar D. Kostic, Marios Giannakis, Hideo Watanabe, Susan Bullman, Danny A. Milner, Curtis C. Harris, Edward L. Giovannucci, Levi A. Garraway, Gordon J. Freeman, Glenn Dranoff, Andrew T. Chan, Wendy S. Garrett, Curtis Huttenhower, Charles S. Fuchs, Shuji Ogino - JAMA Oncology 2015 cited by 661

  8. STK11/LKB1 Deficiency Promotes Neutrophil Recruitment and Proinflammatory Cytokine Production to Suppress T-cell Activity in the Lung Tumor Microenvironment

    Authors: Shohei Koyama, Esra A. Akbay, Yvonne Y. Li, Amir Reza Aref, Ferdinandos Skoulidis, Grit S. Herter-Sprie, Kevin A. Buczkowski, Yan Liu, Mark M. Awad, Warren L. Denning, Lixia Diao, Jing Wang, Edwin R. Parra-Cuentas, Ignacio I. Wistuba, Margaret Soucheray, Tran C. Thai, Hajime Asahina, Shunsuke Kitajima, Abigail Altabef, Jillian D. Cavanaugh, Kevin Rhee, Peng Gao, Haikuo Zhang, Peter E. Fecci, Takeshi Shimamura, Matthew D. Hellmann, John V. Heymach, F. Stephen Hodi, Gordon J. Freeman, David A. Barbie, Glenn Dranoff, Peter S. Hammerman, Kwok‐Kin Wong - Cancer Research 2016 cited by 630

  9. Coinhibitory Pathways in Immunotherapy for Cancer

    Authors: Susanne H.C. Baumeister, Gordon J. Freeman, Glenn Dranoff, Arlene H. Sharpe - Annual Review of Immunology 2016 cited by 921

  10. GM-CSF, IL-3, and IL-5 Family of Cytokines: Regulators of Inflammation

    Authors: Michael Dougan, Glenn Dranoff, Stephanie K. Dougan - Immunity 2019 cited by 458

  11. Prospects for combining targeted and conventional cancer therapy with immunotherapy

    Authors: Philip J. Gotwals, Scott B. Cameron, Daniela Cipolletta, Viviana Cremasco, Adam Crystal, Becker Hewes, Britta Mueller, Sonia Quaratino, Catherine Sabatos-Peyton, Lilli Petruzzelli, Jeffrey A. Engelman, Glenn Dranoff - Nature reviews. Cancer 2017 cited by 965

  12. Discovery and characterization of a selective IKZF2 glue degrader for cancer immunotherapy

    Authors: Simone Bonazzi, Eva d’Hennezel, Rohan E. J. Beckwith, Lei Xu, Aleem Fazal, Anna Magracheva, Radha Ramesh, Artiom Cernijenko, Brandon Antonakos, Hyo‐eun C. Bhang, Roxana García Caro, Jennifer Cobb, Elizabeth Ornelas, Xiaolei Ma, Charles Wartchow, Matthew C. Clifton, Ry R. Forseth, Bethany Hughes Fortnam, Hongbo Lu, Alfredo Csibi, Jennifer Tullai, Seth Carbonneau, Noel M. Thomsen, Jay F. Larrow, B. Chie-Leon, Dominik Hainzl, Yi Gu, Darlene Lu, Matthew J. Meyer, Dylan C. Alexander, Jacqueline Kinyamu-Akunda, Catherine Sabatos-Peyton, Natalie A. Dales, Frédéric J. Zécri, Rishi K. Jain, Janine Shulok, Yinchuan Wang, Karin Briner, Jeffery A. Porter, John A. Tallarico, Jeffrey A. Engelman, Glenn Dranoff, James E. Bradner, Michael Visser, Jonathan M. Solomon - Cell chemical biology 2023 cited by 156

  13. Phase I Trial of Autologous CAR T Cells Targeting NKG2D Ligands in Patients with AML/MDS and Multiple Myeloma

    Authors: Susanne H.C. Baumeister, Joana Murad, Lillian Werner, Heather Daley, Hélène Trebeden‐Negre, Joanina K. Gicobi, Adam Schmucker, Jake Reder, Charles L. Sentman, David E. Gilham, Frédéric Lehmann, Ilene Galinsky, Heidi DiPietro, Kristen Cummings, Nikhil C. Munshi, Richard M. Stone, Donna Neuberg, Robert J. Soiffer, Glenn Dranoff, Jerome Ritz, Sarah Nikiforow - Cancer Immunology Research 2018 cited by 325

  14. Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors

    Authors: Esra A. Akbay, Shohei Koyama, Julián Carretero, Abigail Altabef, Jeremy H. Tchaicha, Camilla L. Christensen, Oliver R. Mikse, Andrew D. Cherniack, Ellen M. Beauchamp, Trevor J. Pugh, Matthew D. Wilkerson, Peter E. Fecci, Mohit Butaney, Jacob B. Reibel, Margaret Soucheray, Travis J. Cohoon, Pasi A. Jänne, Matthew Meyerson, D. Neil Hayes, Geoffrey I. Shapiro, Takeshi Shimamura, Lynette M. Sholl, Scott J. Rodig, Gordon J. Freeman, Peter S. Hammerman, Glenn Dranoff, Kwok‐Kin Wong - Cancer Discovery 2013 cited by 1,242

  15. Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell–driven tumor immunity

    Authors: Lucas Ferrari de Andrade, Rong En Tay, Deng Pan, Adrienne Luoma, Yoshinaga Ito, S Badrinath, Daphne Tsoucas, Bettina Franz, Kenneth F. May, Christopher J. Harvey, Sebastian Kobold, Jason W. Pyrdol, Charles H. Yoon, Guo‐Cheng Yuan, F. Stephen Hodi, Glenn Dranoff, Kai W. Wucherpfennig - Science 2018 cited by 450

  16. Cytokines in cancer pathogenesis and cancer therapy

    Authors: Glenn Dranoff - Nature reviews. Cancer 2004 cited by 1,535

  17. Injectable, spontaneously assembling, inorganic scaffolds modulate immune cells in vivo and increase vaccine efficacy

    Authors: Jaeyun Kim, Aileen W. Li, Young‐Jin Choi, Sarah A. Lewin, Catia S Verbeke, Glenn Dranoff, David Mooney - Nature Biotechnology 2014 cited by 543

  18. Injectable cryogel-based whole-cell cancer vaccines

    Authors: Sidi A. Bencherif, R. Warren Sands, Omar A. Ali, Aileen W. Li, Sarah A. Lewin, Thomas Braschler, Ting‐Yu Shih, Catia S. Verbeke, Deen Bhatta, Glenn Dranoff, David Mooney - Nature Communications 2015 cited by 410

  19. TGFβ-blockade uncovers stromal plasticity in tumors by revealing the existence of a subset of interferon-licensed fibroblasts

    Authors: Angelo L. Grauel, Beverly Nguyen, David A. Ruddy, Tyler Laszewski, Stephanie Schwartz, Jonathan Chang, Julie Chen, Michelle Piquet, Marc R. Pelletier, Yan Zheng, Nathaniel D. Kirkpatrick, Jincheng Wu, Antoine de Weck, Markus Riester, Matt Hims, Felipe C. Geyer, Joel P. Wagner, Kenzie D. MacIsaac, James Deeds, Rohan Diwanji, Pushpa Jayaraman, Yenyen Yu, Quincey Simmons, Shaobu Weng, Alina Raza, Brian Minie, Mirek Dostalek, Pavitra Chikkegowda, Vera M. Ruda, Oleg Iartchouk, Naiyan Chen, Raphaël Thierry, Joseph Zhou, Iulian Pruteanu-Malinici, Claire Fabre, Jeffrey A. Engelman, Glenn Dranoff, Viviana Cremasco - Nature Communications 2020 cited by 203

  20. Increased Regulatory T-Cell Fraction Amidst a Diminished CD4 Compartment Explains Cellular Immune Defects in Patients with Malignant Glioma

    Authors: Peter E. Fecci, Duane A. Mitchell, John F. Whitesides, Weihua Xie, Allan H. Friedman, Gary E. Archer, James E. Herndon, Darell D. Bigner, Glenn Dranoff, John H. Sampson - Cancer Research 2006 cited by 620

  21. A vaccine targeting resistant tumours by dual T cell plus NK cell attack

    Authors: S Badrinath, Maxence O. Dellacherie, Aileen W. Li, Shiwei Zheng, Xixi Zhang, Miguel C. Sobral, Jason W. Pyrdol, Kathryn L. Smith, Yuheng Lu, Sabrina Haag, Hamza Ijaz, Fawn Connor‐Stroud, Tsuneyasu Kaisho, Glenn Dranoff, Guo‐Cheng Yuan, David Mooney, Kai W. Wucherpfennig - Nature 2022 cited by 145

  22. FAP Delineates Heterogeneous and Functionally Divergent Stromal Cells in Immune-Excluded Breast Tumors

    Authors: Viviana Cremasco, Jillian L. Astarita, Angelo L. Grauel, Shilpa Keerthivasan, Kenzie D. MacIsaac, Matthew C. Woodruff, Michael P. Wu, Lotte Spel, Stephen P. Santoro, Zohreh Amoozgar, Tyler Laszewski, Sara Cruz Migoni, Konstantin Knoblich, Anne Fletcher, Martin W. LaFleur, Kai W. Wucherpfennig, Ellen Puré, Glenn Dranoff, Michael C. Carroll, Shannon J. Turley - Cancer Immunology Research 2018 cited by 203

  23. A molecular glue degrader of the WIZ transcription factor for fetal hemoglobin induction

    Authors: Pamela Y. Ting, Sneha Borikar, John Ryan Kerrigan, Noel M. Thomsen, Eamon Aghania, Amelia E. Hinman, Alejandro Reyes, Nicolas Pizzato, Barna D. Fodor, Fabian Wu, Muluken S. Belew, Xiaohong Mao, Jian Wang, Shripad Chitnis, Wei Niu, Amanda Hachey, Jennifer Cobb, Nikolas A. Savage, Ashley Burke, Joshiawa Paulk, Dustin Dovala, James A. Lin, Matthew C. Clifton, Elizabeth Ornelas, Xiaolei Ma, Nathaniel F. Ware, Carina C. Sanchez, John A. Taraszka, Rémi Terranova, Judith Knehr, Marc Altorfer, S. Whitney Barnes, Rohan E. J. Beckwith, Jonathan M. Solomon, Natalie A. Dales, Andrew W. Patterson, J. Wagner, Tewis Bouwmeester, Glenn Dranoff, Susan C. Stevenson, James E. Bradner - Science 2024 cited by 85

  24. Glioblastoma Eradication Following Immune Checkpoint Blockade in an Orthotopic, Immunocompetent Model

    Authors: David A. Reardon, Prafulla C. Gokhale, Sarah R. Klein, Keith L. Ligon, Scott J. Rodig, Shakti Ramkissoon, Kristen L. Jones, Amy Saur Conway, Xiaoyun Liao, Jun Zhou, Patrick Y. Wen, Annick D. Van den Abbeele, F. Stephen Hodi, Lei Qin, Nancy E. Kohl, Arlene H. Sharpe, Glenn Dranoff, Gordon J. Freeman - Cancer Immunology Research 2015 cited by 437